Jean-Francois Hamel and his group are now using the BioAnalyst for real-time monitoring and analysis of fermentation and cell cultures in bioreactors. BioIntelligence Technologies is very proud to have this partnership in place with the objective of improving the results of both organizations through the improvement of the instrument and of the bioprocesses.

For more information regarding the opportunity of establishing partnerships with BioIntelligence Technologies, please contact us at info@biointelligence.com.

About Jean-Francois Hamel and his group at the Massachusetts Institute of Technology (MIT)

Jean-François Hamel is Research Engineer & Lab Director in MIT’s Chemical Engineering Department.  Dr.Hamel is a biological and bioprocessing engineer with extensive experience in both upstream and downstream processing. He is a hands-on teacher and has been an industry consultant for more than 25 years. Dr.Hamel has studied original upstream and downstream problems in varied microbial and cell culture processes, at the bench (down to µL) and pilot scale (up to 1,500 L), and integrated advanced analytical technologies for process improvement. His current projects focus on biofuels from microalgae and yeast, vaccine antigen and monoclonal antibodies from mammalian cells, stem cells, and proteins from microbes, which have been studied in traditional or single-use bioreactors.

About BioIntelligence Technologies Inc.

BioIntelligence Technologies is a private company developing technologies and commercializing products to accelerate the industrial biotechnology revolution. Our team designs products to increase the efficiency of operations, accelerating bioprocess development and increasing bioprocesses profitability. The products we are developing bring highly significant indicators to operators, decision makers, and to scientists, to reduce time and risks of data manipulation and calculations. With our products, people and organization are more efficient and create more value for a given process and a given capacity. The business model we propose is highly attractive and profitable and it is aligned with our clients business.

– 30 –